...
首页> 外文期刊>Brazilian Journal of Microbiology >Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India
【24h】

Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India

机译:印度中部中央邦贾巴尔普尔(Jabalpur)的临床和环境新隐球菌和gryptococcus gattii分离株的抗真菌药敏性

获取原文

摘要

In this study, we present antifungal susceptibility data of clinical and environmental isolates of Central Indian Cryptococcus neoformans (Serotype A, n = 8 and n = 50 respectively) and Cryptococcus gattii (Serotype B, n = 01 and n = 04 respectively). Susceptibilities to fluconazole, itraconazole and ketoconazole were determined by using NCCLS broth micro-dilution methodology. The total number of resistant strains for fluconazole in case of C. neoformans and C. gattii showed a significant difference by using chi-square test (p 0.05*), while considering fisher's exact p value was nonsignificant (p 0.05). However, the total number of resistant strains for itraconazole and ketoconazole was not found statistically significant. A comparison of geometric means of clinical and environmental strains of C. gattii and C. neoformans was not found statistically significant using student ‘t’ test (p value 0.05 NS). Though less, the antifungal data obtained in this study suggests that primary resistance among environmental and clinical isolates of C. neoformans and C. gattii against tested antifungal was present and C. gattii comparatively was less susceptible than C. neoformans var. grubii isolates to fluconazole than to itraconazole and ketoconazole. A continuous surveillance of antifungal susceptibility of clinical and environmental isolates of C. neoformans and C. gattii is desirable to monitor the emergence of any resistant strains for better management of cryptococcosis patients.
机译:在这项研究中,我们介绍了中部印度隐球菌(A型,分别为n = 8和n = 50)和加氏隐球菌(B型,分别为n = 01和n = 04)的临床和环境分离株的抗真菌药敏性数据。使用NCCLS肉汤微稀释法确定对氟康唑,伊曲康唑和酮康唑的敏感性。通过卡方检验,对新孢梭菌和加迪梭菌的氟康唑耐药菌株总数显示出显着差异(p <0.05 *),而考虑到费舍尔的确切p值无统计学意义(p> 0.05)。但是,对伊曲康唑和酮康唑的耐药菌株总数没有统计学意义。使用学生t检验,发现加迪梭菌和新孢梭菌的临床和环境菌株的几何均数比较没有统计学意义(p值> 0.05 NS)。尽管较少,但这项研究中获得的抗真菌数据表明,环境和临床分离的新孢梭菌和加蒂梭菌对测试的抗真菌药物存在主要耐药性,而加蒂梭菌相对于新孢梭菌更不易感。格鲁比对氟康唑的分离比对伊曲康唑和酮康唑的分离。持续监测新福建梭菌和加迪梭状芽胞杆菌的临床和环境分离株的抗真菌药敏性,以监测任何耐药菌株的出现,以便更好地治疗隐球菌病患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号